cover image for summer 2025 New therapies, payer strategies and pipeline updates shaping the future of managed care  Prime Therapeutics /summer-2025-prime-therapeutics-report The Prime Therapeutics...

Read Clinical News: August 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics FDA SAFETY ALERT ON COMPOUNDED...

Journal of Managed Care & Specialty Pharmacy (JMCP)

Read Clinical News: June 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics MDMA-ASSISTED THERAPY FOR PTSD...

Hear some of the latest insights from the annual managed care pharmacy event, where Prime Therapeutics clinical and health outcomes teams presented leading research findings

A roundup of Prime's award-winning presentations and insights at AMCP Nexus in Las Vegas.

More than 300 pharma representatives attended this annual gathering to learn more about what Prime/MRx has to offer

Identifying and managing diabetes and weight loss therapies earns AMCP platinum award

Publications Clinical Highlights: March 2025 Your monthly source for drug information highlights. March 27, 2025 Trending topics As of late February 2025, the United States (U.S.) Centers for...

publications Trending Topics & Drug Approvals: August 2025 Your source for the latest drug information highlights August 29, 2025 Trending Topics Hot topics BARDA research update The United...

Power your success with combined pharmacy and medical data Integrated data. Actionable insights. Pharmacist outreach. All in one innovative product. Breadcrumb Home Our solutions Clinical...

This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.

This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.

This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.

Read Drug Approvals Monthly Update: January 2024 Critical updates in an ever-changing environment. Drug Approval Update Specialty New drugs 12/22/2023 Wainua™ (eplontersen) The United States (U.S.)...

Read Drug Approvals Monthly Update: February 2024 This monthly approval update provides a review of newly approved specialty drugs, recent drug launches, generic updates, new indications and news...

Annual conference gathers 2,500+ managed care leaders to discuss complex health care issues.

13th annual report the preeminent source for medical benefit drug trend

publications Spring 2024 Prime Therapeutics Report March 15, 2024 The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. Our cover story (Page 6)...

Managed Healthcare Executive

publications High-Cost Therapy Profile: March 2025 Pegzilarginase Intravenous (IV), Subcutaneous (SC) | Immedica Metabolic March 14, 2025 Proposed indications Arginase 1 deficiency (ARG1-D)...

Get the most value and best outcomes from C&GT Cell and gene therapies (C&GTs) represent breakthrough science, but often come at a high cost. Breadcrumb Home Our solutions Condition management Cell...

Breadcrumb Home Newsroom Custom Content Publications Drug Approvals Monthly Update: September 2024 PUBLICATIONS Drug Approvals Monthly Update: September 2024 This monthly update of United States...

Biobetters are just a nickname; they’re based on existing biologics but with a few key differences

Read Drug Approvals Monthly Update: June 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

Perspectives High-Cost Therapy Profile: April Detailed information about prademagene zamikeracel Topical surgical application Date High Cost Therapy Profile Gene therapy/Dermatology Prademagene...

PUBLICATIONS FDA Decisions Expected Drug pipeline for January 2025 December 17, 2024 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we have positioned...

Read Drug Approvals Monthly Update: April 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

Drug Approvals Quarterly Update: July 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....

Perspectives High-Cost Therapy Profile: May Detailed information about Fidanacogene elaparvovec-dzkt Intravenous (IV) High Cost Therapy Profile Gene therapy/Hematology Fidanacogene elaparvovec-dzkt...

PUBLICATIONS FDA Decisions Expected: September 2025 Your monthly synopsis of new drugs expected to hit the market August 14, 2025 Drug pipeline for September 2025 At Prime Therapeutics (Prime), we...

PUBLICATIONS FDA Decisions Expected: March 2025 Your monthly synopsis of new drugs expected to hit the market February 14, 2025 Drug pipeline for March 2025 At Prime Therapeutics (Prime), we have...

publications FDA Decisions Expected Drug pipeline for November 2024 October 14, 2024 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we have...

Read Drug Approvals Monthly Update: May 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

publications High Cost Therapy Profile: November 2024 Zenocutuzumab Intravenous (IV) November 20, 2024 Oncology Proposed indications Pancreatic ductal adenocarcinoma (PDAC) and non–small...

publications Trending Topics & Drug Approvals: July 2025 Your source for the latest drug information highlights July 30, 2025 Trending Topics Hot topics Elevidys update Sarepta has resumed...

PUBLICATIONS FDA Decisions Expected: June 2025 Your monthly synopsis of new drugs expected to hit the market May 21, 2025 Drug pipeline for June 2025 At Prime Therapeutics (Prime), we have...

For the first time, Prime Therapeutics hosted the AMCP Nexus specialty keynote, addressing trends in cell and gene therapy and rare disease and immunology categories

Read Drug Approvals Monthly Update: August 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

Breadcrumb Home Newsroom Custom Content Publications FDA Decisions Expected: October 2024 PUBLICATIONS FDA Decisions Expected: October 2024 Your monthly synopsis of new drugs expected to hit the...